“One particular protein plays a crucial role in inflammation. So in our research we are developing an innovative DNA enzyme that prevents high levels of this protein to tackle the inflammation,” states Dr. Veedu from Murdoch University in Australia. With only a$75,000 grant, Drs. Veedu and Wilson are attempting to develop a new, safer, easier to administer drug to combat MS side effects by controlling the inflammation byway of limiting the amount of this protein in one’s body.
About the Author
Melissa Cook is the author of www.MSsymptoms.me. As a retired high school teacher and school district administrator, she chooses to share her MS story in hopes of benefiting others.